drugset
drugset / Trial / NCT03172598

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

NCT03172598 ↗

Phase 2 Completed 61 enrolled Tanabe Pharma Corporation
RandomizedCrossoverDouble-blindTreatment

Summary

A Study to Investigate the Safety, Tolerability and Efficacy of Multiple Doses of MT-8554 in Subjects with Painful Diabetic Peripheral Neuropathy

Timeline

Start
2017-07-25
Primary completion
2018-08-08
Completion
2018-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Elismetrep Small molecule — —

Indications

diabetic polyneuropathy